Lubiprostone Capsule, Gelatin Coated
Product Images NDC 0406-6424

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 0406-6424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lubiprostone 01)

Chemical structure diagram of lubiprostone, showing its molecular configuration including carbon, hydrogen, oxygen, and fluorine atoms.*

FDA Label Image

Principal Display Panel (60 Capsule Bottle Label)

Lubiprostone Capsules 8 mcg gelatin coated, oral dosage form, shown in a label for a 60-capsule package. The label includes the NDC 0406-6408-60 and states that each soft gel capsule contains 8 mcg of lubiprostone. The product is labeled Rx only and distributed by SpecGx LLC.*

FDA Label Image

Principal Display Panel (60 Capsule Bottle Label)

Lubiprostone Capsules 24 mcg gelatin coated oral capsules, package contains 60 capsules. The label specifies that each soft gel capsule contains 24 mcg of lubiprostone and advises swallowing whole without breaking or chewing. Distributed by SpecGx LLC, Webster Groves, MO. Manufactured in Japan, encapsulated in the United States.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.